ROIV ROIV
Company Profile ↓Company Overview
ROIV (ROIV) is a publicly traded company listed on with a market capitalization of $24.92B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Mar 2026 Revenue of $8.26M (-71.6% YoY); net profit $-299.77M.
- Trailing 12 Months Year-on-year growth — revenue -71.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -19.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -19.07% |
| 1 Year: | -71.57% |
Stock Price Performance
| 1 Year: | +200.61% |
| 6 Months: | +57.49% |
| 3 Months: | +22.18% |
| 1 Month: | -4.71% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)53.60 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -19.1% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2020 | Sep 2020 | Dec 2020 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.58M | 1.32M | 5.75M | 7.74M | 13.99M | 24.34M | 4.32M | 12.53M | 17.05M | 21.62M | 3.65M | 15.56M | 7.99M | 4.47M | 9.02M | 2.17M | 1.57M | 2.00M |
| Operating Income | -114.45M | -156.54M | -259.07M | -154.39M | -684.43M | -246.02M | -282.31M | -280.77M | -378.08M | -276.41M | -213.89M | 5.13B | -102.23M | -341.71M | -274.38M | -284.92M | -306.23M | -339.15M |
| Net Income | -3.24M | -35.40M | -261.03M | -82.18M | -208.48M | -284.54M | -331.81M | -291.59M | -352.01M | -291.82M | -304.33M | 5.10B | 95.30M | -230.18M | 169.38M | -223.35M | -113.52M | -265.89M |
| Diluted EPS | - | - | - | -0.13 | -0.32 | -0.41 | -0.48 | -0.42 | -0.49 | -0.38 | -0.40 | 6.03 | 0.12 | -0.31 | 0.23 | -0.33 | -0.17 | -0.38 |
| R&D Expense | 58.73M | 97.41M | 202.26M | 78.52M | 132.10M | 137.34M | 135.83M | 132.00M | 125.53M | 125.13M | 114.79M | 108.15M | 120.51M | 143.07M | 141.59M | 152.92M | 164.57M | 165.38M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | 23.80M | 55.29M | 31.53M | 32.71M | 29.05M | 8.26M |
| Operating Income | -1.07B | -1.35B | -906.76M | 4.50B | -1.00B | -515.07M |
| Net Income | -809.23M | -845.26M | -1.01B | 4.35B | -171.98M | -299.77M |
| Diluted EPS | - | -1.26 | -1.42 | 5.23 | -0.24 | -0.54 |
| R&D Expense | 236.63M | 483.04M | 454.06M | 439.91M | 550.41M | 681.81M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 2.59B | - | 2.39B | 7.22B | 5.44B | 5.71B |
| Current Assets | - | - | - | 1.80B | 6.73B | 5.00B | 5.17B |
| Cash & Equivalents | - | 2.06B | - | 1.68B | 6.49B | 2.72B | 1.42B |
| Inventory | - | - | 0 | 2.76M | 35.25M | - | - |
| Receivables | - | - | 3.88M | 30.38M | 53.55M | - | - |
| Total Liabilities | - | 527.69M | - | 782.02M | 773.95M | 249.74M | 416.27M |
| Current Liabilities | - | 218.96M | - | 272.45M | 266.76M | 149.41M | 281.24M |
| Long Term Debt | - | 170.28M | 210.03M | 375.51M | 430.59M | - | - |
| Total Debt | - | - | - | 481.40M | 53.99M | 100.17M | 107.44M |
| Total Equity | 2.09B | 1.80B | - | 1.16B | 5.97B | 4.69B | 4.53B |
| Shares Outstanding | - | - | - | 760.14M | 806.68M | 695.94M | 720.35M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -552.14M | -677.73M | -843.39M | -765.27M | -839.45M | -750.35M |
| Investing Cash Flow | -31.70M | 303.30M | -44.27M | 5.20B | -1.77B | -682.33M |
| Financing Cash Flow | 456.26M | 306.79M | 499.46M | 419.36M | -1.22B | 134.24M |
| Capital Expenditure | -5.81M | -17.44M | -12.69M | -1.38M | -4.60M | -8.21M |
| Free Cash Flow | -557.94M | -695.16M | -856.08M | -766.65M | -844.05M | -758.56M |
| Share Buybacks | - | - | 0 | 0 | 1.29B | - |
Ratios (Annual)
Figures in %.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | -4,500.5% | -2,444.8% | -2,875.9% | 13,746.9% | -3,453.3% | -6,235.7% |
| Net Margin % | -3,400.9% | -1,528.9% | -3,200.2% | 13,294.2% | -592.0% | -3,629.2% |
| ROE % | -45.0% | - | -87.2% | 72.9% | -3.7% | -6.6% |
| ROCE % | -45.2% | - | -42.8% | 64.7% | -19.0% | -9.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ROIV
ROIV Stock Nears Record High –Retail Traders See Breakout After Surprise Earnings Beat - Stocktwits
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNVlJhNXc4eUhhazROcm1jRmR2OVlYeVltX3lwLUVnMXBOb1B0UG5paHc4WWp1X3JfZUhaZ0l2SXJKeUo1UWpwUmZrTW0wUGJ4MU5LNTd6aUZDSmJ0dUJUTk1aWVVWZWNFMF91QU1Kc09wWVJOV2xHWmJVQzBHTVVxRWEyV1Y2Yy1hVF9ac1…
Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with a 14.74% Potential Upside - DirectorsTalk Interviews
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxNdXo3RkRtM3dHV21zQWJNaWdOWnpLQ2x4VWRnWWo3UnpzWDVvd0MwcnIxREQ0WmllRGx5b1Q0Z1puZm43anFPRkpqY0xoZkRsOUUxU0NIWnBySmdpTXcyaVd5d3QzbEo0cWpOeGp1RkU1VVpmN2gxRkNzUkhQLW1EZllFbHN6REszeTg1VE…
Roivant Sciences Ltd. ($ROIV) CEO 2025 Pay Revealed - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPSW9ZaTJzeno1ZU13YlZQMU1oNkd3QkU5UmZzU0NlTllMSV9wVWtkV1JpQWpSdm01SVltbnR6M2RjMWJNQml0NS1aSEhUSDNKQ1JscEZtajZCMTVJZV90TmxVSlhYYUJ4TnlNMWdrRl9OR3VkdmhNUU1INFF1cmZDRjZRUHM0MzJsUmlUdl…
(ROIV) and the Role of Price-Sensitive Allocations - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPQk5QR3dLLUxPZExUR3Q5NTlmNVI1bVFUelNlYnhKSWlwcU90WndMYVVUTzlfTTlMVF80TWpia1F2RnNBMWdTN1pDbThFV08wcXBhUzE5NVljUkhFRGlmQWYzMDBmSHVpaERfdFNDLVUzZ3lkQ09qR21sY2FNUWxldDNwU0pLNTlzWUEzdD…
Roivant Sciences Ltd. (ROIV): One of the Best Stocks to Buy According to Joe Edelman - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNTWRkaTZzbDJGckxXVFl6QVJzZURfNXNsenRwSUVtdHZGeEk0VnVZczAxQUZva183dk9QZjgwcjFaajRpTDhrcXN1TFliWVVIZUxmTnFmcTE1aDN0NVRhUHVzNUxMbm55OEhOZkw3SGQzUlZyMG5IdlhadkluZkNsUnpkU2R1X0JIaUd2N0…
Roivant Sciences Ltd. Revenue Breakdown – NASDAQ:ROIV - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE80WUNRWXdiakZLaUR5eDR1UlN4VkN0YUJYQUpBQ0JxTVN3X1lYeDV1dnpnRmpSQzJiZmRzc2RzTkk0WE9sbmplUEFTN2dFaUVUMWY0V3FJYXJ6ZjZuVkhPdU1fMEhrNjFyT0JTbXVuVENGTHE1TUxv?oc=5" target="_blank">Roivant…
ROIV — Frequently Asked Questions
What is the current share price of ROIV?
As of 2026-08-05 17:25 PDT, ROIV trades at $34.60 on NASDAQ/NYSE. Its 52-week range is $11.17 to $36.81.
What is the market capitalisation of ROIV?
ROIV has a market capitalisation of $24.92B on NASDAQ/NYSE.
What is the P/E ratio of ROIV?
ROIV trades at a trailing price-to-earnings (P/E) ratio of -64.07. Its price-to-book (P/B) ratio is 5.51.
What is the return on equity (ROE) of ROIV?
ROIV has a return on equity (ROE) of -6.62%. Its return on capital employed (ROCE) is -9.49%.
Is ROIV a good stock to buy?
This page provides a data-driven analysis of ROIV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.